Metastatic Melanoma with Adil Daud, MD and Boris C. Bastian, MD, PhD - Episode 2
Should a second test always be used if results are negative, using a more inclusive test like HxID-BRAF or next-generation sequencing?
CASE: Metastatic Melanoma
Michelle is a 55-year old who was referred by her primary care physician to receive a biopsy for a suspicious mole during a routine visit. Results of the biopsy and other subsequent tests revealed that she had an M1b stage tumor (lung metastasis and a less than ULN LDH level). Her ECOG PS is 0.
She was referred from the community setting to a tertiary center, at which point a second test was conducted using the bioMérieux HxID-BRAF kit. This assay was positive for the BRAF V600K mutation